Cargando…
Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
BACKGROUND: Preclinical data suggest that sunitinib enhances the efficacy of radiotherapy. We tested the combination of sunitinib and hypofractionated image-guided radiotherapy (IGRT) in a cohort of patients with historically incurable distant metastases. METHODS: Twenty five patients with oligometa...
Autores principales: | Tong, Charles C. L., Ko, Eric C., Sung, Max W., Cesaretti, Jamie A., Stock, Richard G., Packer, Stuart H., Forsythe, Kevin, Genden, Eric M., Schwartz, Myron, Lau, K. H. Vincent, Galsky, Matthew, Ozao-Choy, Junko, Chen, Shu-hsia, Kao, Johnny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384658/ https://www.ncbi.nlm.nih.gov/pubmed/22761653 http://dx.doi.org/10.1371/journal.pone.0036979 |
Ejemplares similares
-
Concurrent Chemoradiation for Mediastinal Oligometastases From Cervical Cancer: A Potentially Curative Treatment
por: Bonilla, Carlos E, et al.
Publicado: (2020) -
Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016) -
Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022) -
Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022) -
Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)